[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Harp A posts on X about $vktx, $mdgl, $ptgx, $jnj the most. They currently have X followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Social category influence finance XXXX% stocks XXX%
Social topic influence $vktx #39, $mdgl #14, $ptgx 3.7%, $jnj 3.7%, sentiment 3.7%, combo 3.7%, blockbuster 3.7%, risk and 3.7%, $mtsr XXX%
Top accounts mentioned or mentioned by @bioinvestor24 @wallstsai @doctorsalomon @pawcio2009 @pacha_8x @pharmdca @tbconx @mcuban @costplusdrugs @rhoman1996 @bartelttim @pharmdabbler @jmartin795 @epictrades1 @ccpspy @bernardgoldste6 @dragonmaxgoku @researchpulse1 @blastoisecap @biotechscanner
Top assets mentioned Viking Therapeutics, Inc (VKTX) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Protagonist Therapeutics, Inc (PTGX) Johnson & Johnson (JNJ) Metsera, Inc. Common Stock (MTSR)
Top posts by engagements in the last XX hours
"@rhoman1996 @TBC_on_X @mcuban @costplusdrugs Hi Norman thank you for the reply. Yes I saw $JNJ going for $PTGX. A lot of things happening for $vktx (maintenance trial this month and ER with corporate updates). True there is a high level of shorts but they will need to cover once sentiment continues to strengthen"
X Link @HarpA70278288 2025-10-12T13:24Z X followers, XXX engagements
"@WallStSai I think combo Glp & Mash are the future. Most Pharma headed in this direction. $Mdgl great revenues and increasing with $Vktx having great potential in GLP/GIP as well and perhaps resurrection with 2809"
X Link @HarpA70278288 2025-10-12T13:30Z X followers, XXX engagements
"@rhoman1996 @TBC_on_X @mcuban @costplusdrugs Also MASH spacing is heating up. Initially invested in $Vktx for 2809 and its friendly race with $Mdgl. Look at $mdgl blockbuster revenues and wanting a deal or licenses for 2809 to bring in more cash infusion. Or a BP that wants Mash/obesity as a combo would be awesome"
X Link @HarpA70278288 2025-10-12T13:48Z X followers, XXX engagements
"@Doctor_Salomon @CCP_SPY @bioinvestor24 Lets get something done. More so a partnership as it unlocks a greater value for $vktx"
X Link @HarpA70278288 2025-10-14T02:28Z X followers, XXX engagements
"@WallStSai After buyout can Bakers head over to $Vktx to steady the ship. B*lls to the wall kinda thing"
X Link @HarpA70278288 2025-10-14T21:13Z X followers, XXX engagements
"@BlastoiseCap @Pharmdca That would be too low but would work on a partnership. That way both acquirer and $Vktx still have skin in the game. definitely a win win to commensurate the risk and reward going forward"
X Link @HarpA70278288 2025-10-15T20:30Z X followers, XXX engagements
"@BIOTECHSCANNER @peter_paone Too many people omit this initial step"
X Link @HarpA70278288 2025-10-15T20:55Z X followers, XX engagements
"@Doctor_Salomon @bioinvestor24 Anything new or just rehash of older comments"
X Link @HarpA70278288 2025-10-15T21:04Z X followers, XXX engagements
"@pawcio2009 Ask $mdgl and $vktx too on uncooked alerts :)"
X Link @HarpA70278288 2025-10-17T20:11Z X followers, XXX engagements
"@DrivenSports @bioinvestor24 $vktx for the win :)"
X Link @HarpA70278288 2025-10-19T20:13Z X followers, XXX engagements
"@priyankapandhi8 Needs to gap fill $XXXXX prior yo oral data and rerate to at least minimum $Mtsr buyout"
X Link @HarpA70278288 2025-10-14T16:25Z X followers, XX engagements
"@pawcio2009 Throw in $vktx for good measure and you got a deal"
X Link @HarpA70278288 2025-10-17T17:33Z X followers, XXX engagements
"@Doctor_Salomon @bioinvestor24 @ReneSellmann Last one standing takes the spoils"
X Link @HarpA70278288 2025-10-21T21:19Z X followers, XXX engagements